MICROBIOLOGICAL ASSAY FOR QUANTITATIVE DETERMINATION OF IMIPENEM IN POWDER FOR INJECTION

This work describes the development and validation of a microbiological method using the cylinder-plate assay for quantitative determination of imipenem in powder for injection. The aim was to obtain a low-cost and suitable methodology that can be alternative to physicochemical techniques already described, contributing for the quality control of this antibiotic. Firstly, the analytical conditions were optimized, testing the microorganism, inoculum concentration and best range of sample and standard concentrations, in a way that provides the adequate measurement of the inhibition halos. Staphylococcu s epidermidis ATCC 12228 was selected as test microorganism, as well as 2.0 % of inoculum concentration. The validation protocol followed the official guidelines, and the parameters evaluated were linearity, precision (intermediate precision and repeatability) and accuracy. All standard curves ranging 0.5-2.0 µg mL-1 showed r values higher than 0.999, and ANOVA confirmed that were no deviation from linearity (p-value < 0.05). The method also proved to be precise with RSD (relative standard deviation) values ranging 0.28-0.64 for repeatability and 2.49 for intermediate precision. It was performed three days of experiments, being three assays of eight plates a day. The drug mean content was 101.05%. Accuracy was assessed by recovery test, with standard recovery percentage of 101.70-107.90% (mean recovery = 104.86%), which was considered satisfactory. Therefore, the proposed microbiological method was considered validated and suitable for application in quantitative determination of this drug, being useful for quality control routine.

[1]  N. E. El Zahar,et al.  Spectrophotometric and chemometric methods for determination of imipenem, ciprofloxacin hydrochloride, dexamethasone sodium phosphate, paracetamol and cilastatin sodium in human urine. , 2016, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[2]  P. Shanmugasundaram,et al.  A HIGHLY SENSITIVE STABILITY-INDICATING UPLC METHOD FOR THE DETERMINATION OF RELATED SUBSTANCES IN IMIPENEM AND CILASTATIN FOR INJECTION , 2016 .

[3]  A. Schwarzbold,et al.  A fully validated microbiological assay for daptomycin injection and comparison to HPLC method , 2015 .

[4]  A. Mahmoudi,et al.  Microbiological assay for the analysis of certain macrolides in pharmaceutical dosage forms. , 2015, International journal of pharmaceutics.

[5]  Omar Tabbouche,et al.  First-order derivative ultraviolet spectrophotometry of imipenem–cilastatin formulations , 2014 .

[6]  E. Schapoval,et al.  Quantitative evaluation of besifloxacin ophthalmic suspension by HPLC, application to bioassay method and cytotoxicity studies. , 2014, Talanta.

[7]  P. Jolliet,et al.  A liquid chromatography assay for a quantification of doripenem, ertapenem, imipenem, meropenem concentrations in human plasma: application to a clinical pharmacokinetic study. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[8]  J. Zahar,et al.  Simultaneous determination of three carbapenem antibiotics in plasma by HPLC with ultraviolet detection. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  M. Villar Navarro,et al.  Urea as new stabilizing agent for imipenem determination: electrochemical study and determination of imipenem and its primary metabolite in human urine. , 2008, Talanta.

[10]  D. Nicolau Carbapenems: a potent class of antibiotics , 2008, Expert opinion on pharmacotherapy.

[11]  E. Goldstein,et al.  Two decades of imipenem therapy. , 2006, The Journal of antimicrobial chemotherapy.

[12]  Martin Steppe,et al.  Microbiological assay for the determination of meropenem in pharmaceutical dosage form. , 2005, Journal of pharmaceutical and biomedical analysis.

[13]  E. Schapoval,et al.  Microbiological assay of ketoconazole in shampoo. , 2005, International journal of pharmaceutics.

[14]  Thomas Layloff,et al.  Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic Studies , 1992, Pharmaceutical Research.

[15]  M. Steppe,et al.  Microbiological assay for azithromycin in pharmaceutical formulations. , 2002, Journal of pharmaceutical and biomedical analysis.

[16]  W. Hellinger,et al.  Carbapenems and monobactams: imipenem, meropenem, and aztreonam. , 1999, Mayo Clinic proceedings.

[17]  L. Mandell,et al.  Imipenem and meropenem: Comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effects. , 1998, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

[18]  V. Ródenas,et al.  First- and second-derivative spectrophotometric determination of imipenem and cilastatin in injections. , 1993, Journal of pharmaceutical and biomedical analysis.

[19]  J. French,et al.  Intramuscular imipenem/cilastatin treatment of upper reproductive tract infection in women: efficacy and use characteristics. , 1991, Chemotherapy.

[20]  J. J. Gavin Analytical microbiology. II. The diffusion methods. , 1957, Applied microbiology.